Bridgewater Associates’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-32,402
Closed -$239K 793
2024
Q3
$239K Sell
32,402
-36,188
-53% -$338K ﹤0.01% 759
2024
Q2
$723K Sell
68,590
-10,300
-13% -$131K ﹤0.01% 709
2024
Q1
$1.09M Sell
78,890
-12,046
-13% -$188K 0.01% 563
2023
Q4
$1.77M Sell
90,936
-28,964
-24% -$535K 0.01% 536
2023
Q3
$2.54M Buy
119,900
+23,639
+25% +$614K 0.02% 467
2023
Q2
$3.2M Sell
96,261
-3,596
-4% -$132K 0.02% 390
2023
Q1
$3.93M Sell
99,857
-18,286
-15% -$760K 0.02% 361
2022
Q4
$4.98M Sell
118,143
-20,485
-15% -$788K 0.03% 362
2022
Q3
$4.63M Sell
138,628
-41,545
-23% -$1.73M 0.02% 397
2022
Q2
$7.8M Buy
180,173
+45,959
+34% +$2.11M 0.03% 388
2022
Q1
$6.43M Buy
134,214
+31,840
+31% +$1.58M 0.03% 401
2021
Q4
$5.2M Buy
102,374
+16,218
+19% +$721K 0.03% 289
2021
Q3
$3.49M Buy
86,156
+2,277
+3% +$115K 0.02% 347
2021
Q2
$4.75M Buy
+83,879
New +$4.77M 0.03% 338

Other funds holding NUS

Bridgewater Associates's NUS Position: Q4 2024 in Review

Bridgewater Associates sold out of Nu Skin (NUS) in Q4 2024, closing a stake of 32,402 shares — an estimated $239K sold.

Bridgewater Associates first reported a position in NUS in Q2 2021 and held it in 14 quarters. The position peaked at $7.8M in Q2 2022. 200 funds tracked by Wall St. Rank hold NUS as of Q4 2024.

  • Bridgewater Associates reported no remaining Nu Skin position as of Q4 2024 after selling out during the quarter.
  • Bridgewater Associates sold 32,402 Nu Skin shares in Q4 2024, an estimated $239K.
  • Bridgewater Associates first reported a position in Nu Skin in Q2 2021 and held it in 14 quarters.
  • Bridgewater Associates's Nu Skin position peaked at $7.8M in Q2 2022.
  • 200 funds tracked by Wall St. Rank held Nu Skin as of Q4 2024.

Based on Bridgewater Associates's 13F filing for Q4 2024, filed 13 Feb 2025.